With the unexpected upsurge in pertussis (whooping cough) cases in 2024, many people have asked about booster doses for added protection. Pertussis remains one of the least controlled vaccine-preventable diseases, and it occurs in vaccinated people because vaccine protection fades over time.
A recent study assessed antibody persistence five years after booster vaccination with either a recombinant or chemically detoxified pertussis vaccine.
Pertussis Booster Dose Delivers Lasting Protection
Accelerated Kidney Function Decline Seen With COVID-19 Versus Pneumonia
Decline in estimated glomerular filtration rate more severe among individuals hospitalized with COVID-19
UTI Vaccine Reported Very Effective in Portugal
A recent study found that 73% of adult Portuguese patients with urinary tract infections (UTIs) reported a reduction in symptom severity or duration of illness after treatment with Uromune™ (MV140). This inactivated oral spray serves as a novel sublingual mucosal-based bacterial vaccine.
Cruise Ships and Norovirus Don't Mix
When vacationing on cruise ships in 2024, travelers encountered new environments and met other voyagers, which increased the risk of illness due to contaminated food, water, or, more commonly, through person-to-person contact.
To keep everyone informed about disease outbreaks at sea, the U.S. CDC's Vessel Sanitation Program updated its list of cruise ships reporting illnesses as of December 25, 2024.
Brazil's Extensive Chikungunya Outbreak Impacted by Virus Genotype Adaptation
While over 100 countries have reported Chikungunya virus (CHIKV) outbreaks in 2024, new research indicates measurable genetic differences could be affecting countries differently, such as Brazil and France's La Réunion.
Published by Frontiers Public Health on December 10, 2024, a Review Article stated that CHIKV is mainly transmitted by the invasive mosquito Aedes (Stegomyia) aegypti in tropical and subtropical regions worldwide.
U.S. Health Care Spending Reached $4.9 Trillion in 2023
Health sector’s share of the economy was similar in 2023 and 2022, but lower than in 2020 and 2021, during height of COVID-19
Reporting of Human Adenoviruses Has Declined Since COVID-19
Six HAdV types accounted for 88.3 percent of typed specimens reported during 2017 to 2023
20% of Pertussis Cases Adjacent to I-95
Throughout 2024, pertussis cases have increased across the United States. Preliminary data show that more than six times as many cases have been reported compared to the same time in 2023.
According to the U.S. Centers for Disease Control and Prevention (CDC), the number of pertussis cases (32,176) as of December 14, 2024. Pre-pandemic, about 10,000 cases are typically reported each year.
Caribbean Island Vacationers Infected with Chikungunya, Dengue, Oropouche, and Zika Viruses
This year, there has been a rise in mosquito and insect-borne infections in the Caribbean, prompting many vacationers to seek preventive vaccines for chikungunya (10), dengue (105k), Oropouche virus, and Zika (16) virus diseases.
Countries like Grenada, Barbados, Saint Martin, and the Virgin Islands have reported chikungunya cases in the Caribbean region. And zika cases continue in Puerto Rico in 2024.
COVID-19 Infection Not Linked to Changes in MS Symptom Severity
Immediate effect of COVID-19 infection on the SymptoMScreen total score was minimal